scholarly journals High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

2001 ◽  
Vol 85 (9) ◽  
pp. 1240-1246 ◽  
Author(s):  
P H Cottu ◽  
J M Extra ◽  
M Espie ◽  
J P Marolleau ◽  
A de Roquancourt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Phase Ii Study ◽  
High Dose ◽  
Stem Cell Support ◽  
Cell Support

scholarly journals A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

Cancer ◽  
2004 ◽  
Vol 101 (1) ◽  
pp. 156-163 ◽  
Author(s):  
Shreyaskumar R. Patel ◽  
Nicholas Papadopolous ◽  
A. Kevin Raymond ◽  
Michele Donato ◽  
Chu-Myong Seong ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Poor Prognosis ◽  
Bone Tumors ◽  
Peripheral Blood Stem Cell ◽  
Phase Ii Study ◽  
Blood Stem Cell ◽  
Stem Cell Support ◽  
Cell Support

Sequential Treatment Including High-Dose Chemotherapy With Peripheral Blood Stem Cell Support in Patients With High-Risk Stage II-III Breast Cancer

1998 ◽  
Vol 21 (5) ◽  
pp. 523-531 ◽  
Author(s):  
Lee S. Schwartzberg ◽  
Robert Birch ◽  
William H. West ◽  
Kurt W. Tauer ◽  
Frederick Wittlin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
High Risk ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
High Dose Chemotherapy ◽  
Stage Ii ◽  
High Dose ◽  
Stem Cell Support ◽  
Cell Support

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

Cancer ◽  
1997 ◽  
Vol 80 (7) ◽  
pp. 1221-1227 ◽  
Author(s):  
Carsten Bokemeyer ◽  
Anke Franzke ◽  
J�rg T. Hartmann ◽  
Christoph Sch�ber ◽  
Lubomir Arseniev ◽  
...  
Keyword(s):  
Stem Cell ◽  
Soft Tissue ◽  
Phase I ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Soft Tissue Sarcomas ◽  
Blood Stem Cell ◽  
High Dose ◽  
Stem Cell Support ◽  
Cell Support

HIGH DOSE 90Y Mx-DTPA-BrE-3 AND AUTOLOGOUS HEMATOPOIETIC STEM CELL SUPPORT (AHSCS) FOR THE TREATMENT OF ADVANCED BREAST CANCER

1994 ◽  
Vol 16 (2) ◽  
pp. 161 ◽  
Author(s):  
S. M. Stemmer ◽  
T. Johnson ◽  
R. Kasliwal ◽  
J. Lear ◽  
S. Matthes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Advanced Breast Cancer ◽  
Hematopoietic Stem Cell ◽  
Advanced Breast ◽  
High Dose ◽  
Hematopoietic Stem ◽  
Stem Cell Support ◽  
Cell Support

Single-Agent Paclitaxel in Patients With Metastatic Breast Cancer Receiving High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

1999 ◽  
Vol 22 (2) ◽  
pp. 162-167
Author(s):  
L. S. Schwartzberg ◽  
C. H. Weaver ◽  
R. Birch ◽  
R. Giudice ◽  
E. Sobong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Metastatic Breast Cancer ◽  
Peripheral Blood Stem Cell ◽  
Single Agent ◽  
Metastatic Breast ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Stem Cell Support ◽  
Cell Support

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

1999 ◽  
Vol 44 (0) ◽  
pp. S13-S17 ◽  
Author(s):  
S. Hohaus ◽  
S. Martin ◽  
A. Schneeweiß ◽  
M. T. Voso *, ‡ , R. F. Schlenk ◽  
D. Wallwiener ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Peripheral Blood Stem Cell ◽  
High Dose ◽  
High Dose Therapy ◽  
Stem Cell Support ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Cell Support ◽  
Risk Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document